Market Access News | pharmaphorum

News

The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review.

News

The Senate has endorsed Martin Makary as FDA Commissioner and Jay Bhattacharya as NIH director, while Mehmet Oz moves closer to leading the CMS.

News

Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis.

News

President Trump has nominated another candidate to lead the CDC, acting director Susan Monarez, after withdrawing support for his first choice.

News

AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.

News

Novartis' oral complement inhibitor Fabhalta has become the first approved treatment for rare kidney disease C3G as it chases a $3bn sales target.